Table Of Content

AUTHOR INDEX Adams, W.H., 148 Karas, A.Z., 15, 44 Kraft, S.L., 112 Borkowski, R., 44 Brinson, J., 220 McCarthy, T.C., 213 Broadstone, R.\ McCullough, S., 220 Mahony, O., 207 Court, M.H., 38 Mitchell, S.K., 160 Proulx, J., 227 Daniel, G.B., 160 Quandt, J.I Forrest, L.J., 170 Reichle, J.K., 177 Gavin, PR., 112 Rha, J.-Y., 207 Glowaski, M.M., | Rozanski, E.A.. Greene, S.A LO Schwarz, L.A., Hotfman, A.M £23 Snaps, F,, 177 Thomas, WB., 12 9 Tidwell, A.S., 65, 187 Wetmore, L.A., | Clinical Techniques in Small Animal Practice, Vol 14, No 4 (November), 1999: p 242 AUTHOR INDEX Adams, W.H., 148 Karas, A.Z., 15, 44 Kraft, S.L., 112 Borkowski, R., 44 Brinson, J., 220 McCarthy, T.C., 213 Broadstone, R.\ McCullough, S., 220 Mahony, O., 207 Court, M.H., 38 Mitchell, S.K., 160 Proulx, J., 227 Daniel, G.B., 160 Quandt, J.I Forrest, L.J., 170 Reichle, J.K., 177 Gavin, PR., 112 Rha, J.-Y., 207 Glowaski, M.M., | Rozanski, E.A.. Greene, S.A LO Schwarz, L.A., Hotfman, A.M £23 Snaps, F,, 177 Thomas, WB., 12 9 Tidwell, A.S., 65, 187 Wetmore, L.A., | Clinical Techniques in Small Animal Practice, Vol 14, No 4 (November), 1999: p 242 SUBJECT INDEX Abscess bacterial, 14] , 143 Bronchoalveolar lavage (BAL) \cepromazine, 16 collection technique, 221 Acidosis normal values, 225 metabolic, 57, 64 proc edure, 209-211 respiratory, 229 Bronchoscopy Airway anatomy, 208 anesthesia for, 208 Alkalosis, respiratory, 229 complications, 208-209 \lpha-2 agonists. See also Medetomidine; Xylazine contraindications, 209 for anesthesia, 10-14 evaluation for, 208 antagonism of, 13 indications, 207, 208 sedation protocol, 16 instrumentation, 207-208 Alpha-2 antagonists, 13 positioning for, 208 Alveolar gas equation, ) 228 special applications, 209-211 Analog-to-digital conversion, 65 Brushing, bronchial, 211, 221 Anesthesia Butorphanol, 17, 45 a-2 agonists for, 10-14 BWBP (barometric whole-body plethysmography), 238 balanced techniques, 27-36 for bronchoscopy, 208 apnography, 230 for laparoscopy, 52-54 ardiac catheterization, for pulmonary hypertension, 234-235 for laser surgery, 50-52 ardiovascular system prolonged recovery from, 56-64 dysfunction, prolonged anesthetic recovery and, 56 propofol for, 1-5 evaluation, in pulmonary hypertension, 233-234 for rabbits, 45-48 preexisting disease, propofol effects on, 6 of sighthounds, 38-4 propofol effects on, 5-6 for thoracosc Opy, 92-55 ats Anesthetic agents. See also specific anesthetic agents balanced anesthetic techniques, 27-36 overdosage, 56 intracranial neoplasia, 112-122 Angiography, CT, 108-109 respiratory parameters, normal values for, \nticholinergic agents, with a-2 agonists, 10 sedation/chemical restraint, 15-26 Arachnoid cysts, 128-129 entral nervous system Arterial blood gas compromise, prolonged anesthetic recovery and, 59 analysis, 227 depression, prolonged anesthetic recovery and, 57 interpretation, 229-230 postoperative alterations, 61 oxygenation and, 227-228 preexisting disease, propofol effects on, 6 respiratory acidosis and, 229 erebellar hypoplasia, 127-128 respiratory alkalosis and, 229 erebritis, bacterial, 141, 143 sampling, 227 erebrovascular malformations, 133 ventilation and, 228-229 hemical restraint agents, 17 Atelectasis, pulmonary hiari malformations, 126-127 computed tomography of, 202-203 horoid plexus papillomas, 113 ultrasonography of, 192-193 oenurosis, 144-145 \tipamezole, 13 ompliance, lung, 238-240 \tropine, 45 nRNRR RRoRA mRRpu ted tomography (CT). See also specific imaging concepts BAL. See Bronchoalveolar lavage angiography, 108-109 Balanced anesthetic techniques, 27-36 brain infarction, 133-134 Barometric whole-body plethysmography (BWBP), 238 concepts, 65-109 Benzodiazepines, 16 contrast enhancement, 83, 86-87, 90 Biopsy degenerative spinal disease, 151-152 bronchoscopy-guided, 221 elbow, 177-182 endobronchial, 211 eye/orbit, 160-161 open-chest lung, 221-222 functional, 108-109 Brain head disorders, 170-175 activation, 108 imaging strategy for spine, 148-149 cerebrovascular malformations, 133 infectious spinal disease, 154-155 development, disorders of, 125-129 interventional techniques, 109 hemorrhage, intraparenchymal, 129-133 intracranial hemorrhage, 129-130 infarction, 133-135 intracranial tumor features, 115-122 infectious/inflammatory diseases of, 138-145 lung, 198-205 perfusion imaging, 94, 101-102, 108 spinal anatomy, normal, 149-150 traumatic injuries, 135-138 spinal neoplasia, 155-157 tumors, 112-122 technical recommendations, 112-113 2 Clinical Techniques in Small Animal Practice, Vol 14, No 4 (November) , 1999: pp 243-246 three-dimensional, 109 Halothane, 17 VS. Magnetic resonance Head trauma, 13 ontrast enhancement Hemorrhage computed t infarction from intract intracranial subarachnoid, 13 ont High-resolution computed tomography (HRCT), of lung, 198 a2\ 05 Hilar lymph node enlargement, 218 Hippocampal injury, after seizure, 134-135 l (high-resolution computed tomography brush sampling Hydrocephalus, 125-126 interpretation « Hypercarbia, 64 respiralo! Hypoglycemia, 5 Hypotension, 58 mallormations Hypothermia, 58 rmni Hypothyroidism Hypoventilation Hypoxemia, 62 infiltrative computed tomography of Imaging methods. See specific imaging methods ull rasonography Imaging planes, 66 Infarction, brain, 133 Inhalant anesthetics i processing Distemper encephalitis in balanced anesthetic technique prolonged 1 elimination of, 59 sedation protocols, 15, 17 balanced anesthet ' Injectable anesthetics, prolonged elimination of, 59-60 intracranial neoplasia nterventional procedures respiratory parameters computed tomography for, 109 sedation/chemical restraint ultrasonography for, 194 sighthounds, anes ntracranial hemorrhage Double echo technique, 79 computed tomography of, 129-130 Dystrophic mineralization « magnetic resonance imaging ol, 130-133 Echo time (TI ntracranial neoplasia, CT/MRI diagnosis of Intraparenchymal hemorrhage, 129-133 I lbow computed tomography, 177 ntubation, of rabbits, 46-48 magnetic resonance nversion recovery, 81, 83 Encephalitis, | Isoflurane, 17 End-tidal carbon dioxide analysis Ketamine Eosinophilic inflammation, 2>2?2 for chemical restraint, 15, 17 Epidural hematoma, 112365 -136 in rabbit sedation protocol, 45 Epidural opioids, in balanced an Kidney disease Eve preexisting, propofol effects on, 6 ballistic penetration of, 168 prolonged anesthetic recovery and, 57 carcinoma ol, 168 : : computed tomography, 160-161 Laparoscopy, anesthesia for, 52-54 magnetic resonance imaging, 161-165 aser surgery, anesthesifaor , 50-52 Liver Failure to breathe, postoperative, 61 disease, prolonged anesthetic recovery and, 57 Faraday’s law of induction, 75 preexisting disease, propofol effects on, 6 Fast imaging, 90 propofol metabolism, breed-related differences in, 38 Fat saturation, 83 Local anesthetics, for sedation protocol, 19-24 Feline infectious peritonitis (FIP), 140 ung Field of view (FOV), 66 computed tomography, 198-205 FIP (feline infectious peritonitis), 140 mechanics, 238-240 Flexible bronchoscope, 207-208 scintigraphy, 194-198 Fluid attenuated inversion recovery (FLAIR ultrasonography, 187-194 FOV (field of view), 66 Functional computed tomography, 108-109 Magnetic resonance angiography (MRA), 90, 94 Fungal infections, of brain, 140 Magnetic resonance imaging (MRI). See also specific imaging concepts brain infarction, 134 Glycopyrrolate, 25, 45 concepts 65-109 Gradient echo pulse sequences, 80-81 degenerative spinal disease, 152-154 Granulomatous meningoenc ephalomyelitis elbow, 182-185 Gray scales eye/orbit, 161-165 CTI head disorders, 170-175 MRI infectious spinal disease, 155 Gyromagnetic ratio constant, 75 intracranial hemorrhage, 130-133 244 SUBJECT INDEX intracranial tumor features, 115-122 Pneumothorax spinal anatomy, normal, 150-151 computed tomography of, 203 spinal neoplasia, 157-158 thoracoscopy of, 218 strategy for spine, 149 ultrasonography of, 193 technical recommendations, 112-113 2 Primary pulmonary disease, 219 vs. computed tomography, 113-115 Propofol Mandible imaging, 171-172 adverse reactions, 5-8 Masses. See Neoplasia clinical uses, 1-5 Matrix, resolution and, ¢ liver metabolism, breed-related differences in. 38 Maxilla imaging, 171-17 pharmacokinetics/pharmacodynamics, 5 Medetomidine sedation protocol, 16 antagonism of, 13 Proton density-weighted images. 78-79 combination therapy, 11-13 Pulmonary consolidation ultrasonography of, 189-19] sedation protocol, 16 Pulmonary dysfunction, prolonged anesthetic recovery and Pulmonary embolism selection of, 1] computed tomography of 205 Meningiomas, 113 scintigraphy of, 197 Meningitis, 138-139 Pulmonary function tests Metabolic acidosis, 57 Pulmonary hypertension Midazolam cardiac catheterization, 234 rabbit sedation protocol and, cardiopulmonary evaluation risks/benefits, 16 definitioonf , 231] Morphine, 17 history, 232 MRA (magnetic resonance angiography 90, 94 laboratory data 2 33 MRI. See Magnetic resonance imaging pathophysiology/physiology, 23 Multiecho techniques, 90 physical examination, 233 Muscle weakness, prolonged anesthetic recovery and, 59 Pulse oximetry, 230 Nasal adenocarcinomas, 11] Rabbits, sedation/anesthesia for, 44-49 Nasal cavity imaging, 172-173 Repetition times (TR), 77 Nasal tumor, diagnosis of, 166-167 Resolution, 65-73 Nasopharynx imaging, 172> -1o7o/ 3 Resonant frequency, 75 Necrotizing encephalitis, 140-141 Respiratory acidosis 7 9 Neoplasia Respiratory alkalosis, 229 brain, 112-122 Respiratory system computed tomography of, 199-202 cytologic interpretations intrathoracic, 218 evaluation, in pulmonary hypertension, 233-234 pulmonary, 192, 199-202 monitoring, 227-230 spinal, 155-158 parameters, normal values for, 238 ultrasonography of, 192 propofol effects on, 6 Retrobulbar tumor, diagnosis of, 166-167 NEX (number of excitations), 71 Nitrous oxide, in balanced anesthetic technique, 28-29 Scintigraphy, lung, 194-198 Number of excitations (NEX), 71 Sedation Number of signals averaged (NSA), 71 adjunctive therapy, 19-24 drug selection for, 15-25 Opioids equipment for, 18 with a-2 agonists, 10 preparation for, 15-18 in balanced anesthetic technique, 29-36 propofol for, 1-5 prolonged elimination of, 59 of rabbits, 44-45 for sedation protocols, 15, 17 recovery from, 24-25, 49 Optic neuritis, diagnosis of, 167-168 Sedative-hypnotics, 15, 16 Orbit imaging Seizures, hippocampal injury after, 134-135 clinical examples, 165-168 Sighthounds, anesthesia of, 38-42 computed tomography, 160-161 Signal-to-noise ratio, 66 magnetic resonance imaging, 161-165 Spatial resolution, 72 Oxygenation, arterial blood gases and, 227-228 Spinal opioids, in balanced anesthetic technique, 31-34 Oxymorphone, 17 Spin density (proton density-weighted images), 78-79 Spine Paranasal sinus imaging, 172-173 degenerative diseases, 151-154 Parasitic infections imaging strategies, 148-149 of brain, 143-145 infectious diseases, 154-155 cytologic interpretations, 224 neoplastic diseases, 155-158 Partial volume averaging artifact, 66 normal anatomy, 149-151 Pentothal, 16 vascular diseases, 158 Pericardial effusion, 218-219 Spin echo, 77 Pituitary tumors, 113 Spin echo pulse sequences, 75-80 Pleural effusion, 218 Spirometry, 237 SUBJECT INDEX STIR images, 81, 8»32 Iransdermal opioids, in balanced anesthetic technique, 34-36 Subarachnoid hemorrhage, 137 [ranstracheal wash (TTW), collection technique, 220-221 Subdural hematoma, 136-137 I'l relaxation, 77, 80 [2 relaxation times, 75, 77, 79 IBFVL (tidal breathing flow-volume loops), 237-238 [l weighting T2 de irves, / 79 [2 weighting, 7 Tt 10 time [ympanic bullae, imaging of, 1 mporal resolution [Thoracoscopy Uveitis, diagnosiosf , 165-166 anesthesia for, 52-55 findings, 217-219 Vascular disease, spinal, 158 indications, 213-214 Vascular pain, propofol effects on, 6 instrumentation, 214-215 Ventilation, arterial blood gases and, 228-229 patient preparation, 215 portal access, 216-217 Windowing, CT, 74, 75, 76 portal closure/recovery >] Xylazine technique, 215-216 antagonism of, 13 Tidal breathing flow-volume loops (TBFVI combination therapy, 11-13 Tiletamine, 17 rabbit sedation protocol and, 45 Tolazoline, 13 sedation protocol, 16 Tomography, 65, 66 'R (repetition times selection of, 10-1 | [ranquilizers, 15, 16 Yohimbine, 13 SUBJECT INDEX